4th Quarter - Report

CGCN GROUP, LLC for VERTEX PHARMACEUTICALS INCORPORATED

Firm
Client
Income
$25,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Access to innovative non-opioid medicines.

LobbyistCovered position, as disclosed
SAM GEDULDIG —
JILL HAMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Access to innovative non-opioid medicines; Alternatives to PAIN, H.R. 714; Alternatives to PAIN, S. 3832

LobbyistCovered position, as disclosed
SAM GEDULDIG —
JILL HAMAKER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 3832 (118th), H.R. 714 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.